# Accuryn Medical Lands Multi-Year Vizient Agreement for Fluid Monitoring System

> Accuryn Medical signed a multi-year capital equipment supplier agreement with Vizient, giving eligible hospitals contracted pricing on its urine output monitoring system.

- Published: 2026-11-11T17:45:59+00:00
- Section: Partnerships
- Author: News Desk
- URL: https://newsforagent.com/news/2026-11-11/accuryn-medical-vizient-supply-agreement
- Source: [PR Newswire](https://www.prnewswire.com/news-releases/accuryn-medical-announces-multi-year-capital-equipment-supplier-agreement-with-vizient-for-advanced-fluid-monitoring-302936790.html)

## Key takeaways

- Accuryn Medical entered a multi-year capital equipment supplier agreement with Vizient on November 11, 2026.
- Eligible Vizient clients gain contracted pricing and negotiated purchasing terms for the Accuryn Monitoring System.
- The Accuryn system automates urine output measurement and provides real-time trends and alerts based on KDIGO criteria.

Accuryn Medical announced on November 11, 2026 a multi-year capital equipment supplier agreement with Vizient covering its advanced fluid monitoring products. The agreement gives eligible Vizient clients access to contracted pricing and negotiated purchasing terms for the Accuryn Monitoring System and associated products covered by the agreement, according to [PR Newswire](https://www.prnewswire.com/news-releases/accuryn-medical-announces-multi-year-capital-equipment-supplier-agreement-with-vizient-for-advanced-fluid-monitoring-302936790.html).

## How the Accuryn Monitoring System Works

The Accuryn Monitoring System automates urine output measurement and provides real-time trends and alerts based on the urine output guidelines established by Kidney Disease: Improving Global Outcomes (KDIGO) criteria. The system combines smart urinary catheter technology with urine output monitoring, core body temperature measurement, and continuous intra-abdominal pressure monitoring. These capabilities support clinicians as they assess critically ill patients for acute kidney injury and monitor changes over time.

Mike Schrader, Chief Executive Officer of Accuryn Medical, said: "We are pleased to enter into this agreement with Vizient and expand access to technology that supports monitoring for acute kidney injury." He added: "Changes in urine output can provide an early indication of acute kidney injury (AKI) and kidney distress, but intermittent measurements can make those changes difficult to recognize promptly. Accuryn gives care teams continuous visibility into urine output to support earlier recognition and informed clinical decisions."

The agreement provides a purchasing pathway for eligible [Vizient](https://akta.pro/company-profiles/0003y4r/vizient) clients seeking to implement advanced kidney health and fluid monitoring. Hospitals interested in product availability, contract pricing activation, or a demonstration can contact Accuryn Medical, the company said. Accuryn Medical develops medical technology that provides clinicians with timely information about kidney health and fluid status in critically ill patients and is headquartered in Hayward, California, according to its [company website](https://accuryn.com).

Vizient has recently recognized other healthcare technologies. On November 5, 2026, PSG Global Solutions announced that its generative AI solution Anna AI received an Innovative Technology designation from Vizient, according to PR Newswire. On October 29, 2026, LanguageLine's AI Translation App received a Vizient Innovative Technology designation after being evaluated at the Vizient Innovative Technology Exchange in Las Vegas, PR Newswire reported.

## Vizient Contract Details for Hospitals

The agreement covers the Accuryn Monitoring System and associated products covered by the agreement.

## Companies in this story

- Accuryn Medical · website: https://accuryn.com
- [Vizient company profile](https://akta.pro/company-profiles/0003y4r/vizient) · website: https://www.vizientinc.com

---
News for Agent · https://newsforagent.com/llms.txt